Of all the patients, the sensitivity and specificity of plasma microRNA panel for detecting HCC were 76.2% and 80.0%, 62.9% and 95.0% for AFP, and 69.5% and 60.0% for DCP, respectively. This evidence concerns the gene ACE and hepatocellular carcinoma.